Gastrointestinal perforation during treatment with erlotinib plus bevacizumab in two patients with non‑small cell lung cancer exhibiting epidermal growth factor receptor mutations: A case report
2017 ◽
Vol Volume 10
◽
pp. 1757-1766
◽
2018 ◽
Vol 56
(2)
◽
pp. 179-183
◽